EASL

1 stories · following the connections

Business

Galectin Therapeutics Late-Breaker Presentation at The International Liver Congress Reinforces and Extends the Positive Effects of GR-MD-02 in Patients With NASH Cirrhosis

By Nasdaq OMXApr 16, 2018, 12:00 PM UTC